Share Email Print

Proceedings Paper

Endovascular photodynamic therapy inhibits intimal hyperplasia PTA in a rat model
Author(s): Edward E. Gabeler M.D.; Richard van Hillegersberg; R. G. Statius van Eps; Wim Sluiter; D. Hayes M.D.; Hero van Urk
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Background: Vascular restenosis due to intimal hyperplasia (IH) and negative vascular remodeling attenuates long-term patency of vascular interventions like PT(C)As. A new adjuvant approach to PT(C)A is endovascular PDT, which is based on local cytotoxicity by intracellular activation of aminolevulinic acid included protoporfyrin IX with laser. Aim: To prevent restenosis by inhibiting IH with endovascular photodynamic therapy. Methods: Male Wistar rats were subdivided into four groups, the sham group, the IH reference-group with PTA induced denudation of the right iliac artery, and both the PTA+light only group and PTA +PDT group illuminated at 0,12.5, 25 and 50 Joule per cm diffuser length applied at 100 mW per cm diffuser length. Results: IH increased from 0 02 at 1 week to 0.13 mm2 at 4 weeks. After 4 weeks, IH was 0.14mm2 in the PTA +LO group compared to 0.002 mm2 in the PTA+PDT group at 50 Joule per cm diffuser length, whereas the media remained. Conclusion: A single endovascular PDT treatment adjuvant to PTA inhibits IH after 4 weeks at an optimal light dosimetry of 50 Joules per cm diffuser length and 3 hours after ALA application in this IH model. Therefore, endovascular PDT is a promising therapy to prevent restenosis after vascular interventions.

Paper Details

Date Published: 31 January 2001
PDF: 10 pages
Proc. SPIE 4156, Clinical Lasers and Diagnostics, (31 January 2001); doi: 10.1117/12.413698
Show Author Affiliations
Edward E. Gabeler M.D., Erasmus Medical Ctr. of Rotterdam (Netherlands)
Richard van Hillegersberg, Erasmus Medical Ctr. of Rotterdam (Netherlands)
R. G. Statius van Eps, Erasmus Medical Ctr. of Rotterdam (Netherlands)
Wim Sluiter, Erasmus Medical Ctr. of Rotterdam (Netherlands)
D. Hayes M.D., Erasmus Medical Ctr. of Rotterdam (Netherlands)
Hero van Urk, Erasmus Medical Ctr. of Rotterdam (Netherlands)

Published in SPIE Proceedings Vol. 4156:
Clinical Lasers and Diagnostics
Patrick Brouwer, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?